Solubilization of the alternative oxidase of cuckoo-pint (Arum maculatum) mitochondria. Stimulation by high concentrations of ions and effects of specific inhibitors.
Selective solubilization of cyanide- and antimycin-insensitive duroquinol oxidase activity from cuckoo-pint (Arum maculatum) mitochondria was achieved using taurocholate. Inhibitor-sensitivities and water-forming DQH2 (tetramethyl-p-hydroquinone, reduced form): O2 stoichiometry were the same for the alternative oxidase of intact Arum mitochondria. Cyanide-insensitive oxidation of DQH2 by intact and solubilized mitochondria was stimulated by up to four-fold by high concentrations of anions high in the Hofmeister series, such as phosphate, sulphate or citrate. Optimal (0.7 M) sodium citrate increased Vmax. for DQH2 oxidation by the solubilized preparation from 450 to 2400 nmol of O2 X min-1 X mg of protein-1 and decreased the apparent Km for DQH2 from 0.53 to 0.38 mM. Inhibition of solubilized DQH2 oxidase activity by CLAM (m-chlorobenzhydroxamic acid) and SHAM (salicylhydroxamic acid) was mixed competitive/non-competitive, with apparent inhibition constants for CLAM of 25 microM (Ki) and 81 microM (KI) and for SHAM of 53 microM (Ki) and 490 microM (KI). Propyl gallate and UHDBT were non-competitive inhibitors with respect to DQH2 (apparent Ki = 0.3 microM and 12 nM respectively). Low concentrations of C18 fatty acids selectively inhibited cyanide-insensitive oxidation by intact and solubilized mitochondria, and inhibition was reversed by 1% (w/v) bovine serum albumin. Inhibition was competitive with DQH2, suggesting that fatty acids interfere reversably with the binding of DQH2 to the oxidase. These results tend to support the view that quinol oxidation by the alternative pathway of Arum maculatum mitochondria is catalysed by a quinol oxidase protein, rather than by a non-enzymic mechanism involving fatty acid peroxidative reaction. [Rustin, Dupont & Lance (1983) Trends Biochem. Sci. 8, 155-157; (1983) Arch. Biochem. Biophys. 225, 630-639].
D002951:Citrates / Q000494:pharmacology; D019343:Citric Acid; D005230:Fatty Acids, Nonesterified / Q000494:pharmacology; D006873:Hydroquinones / Q000378:metabolism; D007477:Ions / Q000494:pharmacology; D008928:Mitochondria / Q000201:enzymology; D010088:Oxidoreductases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D010944:Plants / Q000187:drug effects / Q000201:enzymology*; D011435:Propyl Gallate / Q000494:pharmacology; D012457:Salicylamides / Q000494:pharmacology; D012995:Solubility; D013844:Thiazoles / Q000494:pharmacology
C025993:5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole; D002951:Citrates; D005230:Fatty Acids, Nonesterified; D006873:Hydroquinones; D007477:Ions; D012457:Salicylamides; D013844:Thiazoles; D019343:Citric Acid; D011435:Propyl Gallate; C005703:salicylhydroxamic acid; D010088:Oxidoreductases; C020094:duroquinol oxidase; C016421:duroquinol